These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32666900)

  • 1. Comparison of CHA2DS2-VASc and C2HEST scores for predicting the incidence of atrial fibrillation among patients with end-stage renal disease.
    Hu WS; Lin CL
    Perfusion; 2020 Nov; 35(8):842-846. PubMed ID: 32666900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of new-onset atrial fibrillation for general population in Asia: A comparison of C2HEST and HATCH scores.
    Hu WS; Lin CL
    Int J Cardiol; 2020 Aug; 313():60-63. PubMed ID: 32336574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying At-Risk Patients for Sustained Atrial High-Rate Episodes Using the C
    Li YG; Pastori D; Miyazawa K; Shahid F; Lip GYH
    J Am Heart Assoc; 2021 Mar; 10(6):e017519. PubMed ID: 33666093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world observational study of assessment of CHA2DS2-VASc, C2HEST and HAVOC scores for atrial fibrillation among patients with rheumatological disorders: a nationwide analysis.
    Hu WS; Li Lin C
    Postgrad Med J; 2022 Nov; 98(1165):837-841. PubMed ID: 37063040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study.
    Saliba W; Gronich N; Barnett-Griness O; Rennert G
    Am J Med; 2016 Aug; 129(8):843-9. PubMed ID: 27012854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C
    Özmen G; Koca F
    Kardiologiia; 2023 Jun; 63(6):52-60. PubMed ID: 37470734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CHA
    Hu WS; Lin CL
    BMJ Open; 2018 Mar; 8(3):e020065. PubMed ID: 29567851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of CHA
    Hu WS; Lin CL
    Atherosclerosis; 2017 Nov; 266():205-211. PubMed ID: 29049919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of changes in the adapted diabetes complications severity index and CHA2DS2-VASc score for atrial fibrillation risk stratification in patients with type 2 diabetes mellitus: A nationwide cohort study.
    Hu WS; Hsieh MH; Lin CL
    Int J Cardiol; 2018 Oct; 269():122-125. PubMed ID: 30037627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining age stratum of the C
    Li YG; Bai J; Zhou G; Li J; Wei Y; Sun L; Zu L; Liu S
    Eur J Intern Med; 2021 Aug; 90():37-42. PubMed ID: 33975769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHA2DS2-VASc and SAMe-TT2R2 scores as predictors of recurrence for nonvalvular atrial fibrillation patients on vitamin K antagonists after radiofrequency catheter ablation.
    Zhao J; Zhou D; Chen M; Zhuo C; Lin Z; Zheng L; Wang Q
    J Cardiovasc Med (Hagerstown); 2020 Mar; 21(3):200-208. PubMed ID: 31977539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus.
    Kapłon-Cieślicka A; Budnik M; Gawałko M; Peller M; Gorczyca I; Michalska A; Babiarz A; Bodys A; Uliński R; Żochowski M; Scisło P; Kochanowski J; Filipiak KJ; Opolski G
    Heart; 2019 Sep; 105(17):1310-1315. PubMed ID: 31040170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHA
    Hu WS; Lin CL
    Int J Cardiol; 2017 May; 235():56-60. PubMed ID: 28262350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
    Saliba W; Rennert G
    Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the C
    Rasmussen LF; Andreasen JJ; Lundbye-Christensen S; Riahi S; Johnsen SP; Lip GYH
    J Cardiothorac Vasc Anesth; 2022 Oct; 36(10):3730-3737. PubMed ID: 35581051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study.
    Hu WS; Lin CL
    Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Value of the CHADS
    Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of new-onset atrial fibrillation with the C
    Pastori D; Menichelli D; Romiti GF; Speziale AP; Pignatelli P; Basili S; Violi F; Cangemi R
    Infection; 2024 Aug; 52(4):1539-1546. PubMed ID: 38700657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.